These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 160296)

  • 1. Relation between endocrine function and survival of patients with breast cancer after hypophysectomy.
    Wang DY; Bulbrook RD; Rubens RD; Bates T; Knight RK; Hayward JL
    Clin Oncol; 1979 Dec; 5(4):311-6. PubMed ID: 160296
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of pituitary function and clinical response after transphenoidal and transfrontal hypophysectomy for advanced breast cancer.
    Bates T; Rubens RD; Bulbrook RD; Goodwin PR; Wang DY; Knight RK; Hayward JL
    Eur J Cancer (1965); 1976 Oct; 12(10):775-82. PubMed ID: 136353
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormonal changes following hypophysectomy in humans.
    Lachelin GC; Yen SC; Alksne JF
    Obstet Gynecol; 1977 Sep; 50(3):333-9. PubMed ID: 142934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrinologically incomplete transethmoidal trans-sphenoidal hypophysectomy with relief of bone pain in breast cancer.
    LaRossa JT; Strong MS; Melby JC
    N Engl J Med; 1978 Jun; 298(24):1332-5. PubMed ID: 651992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anterior pituitary function following hypophysectomy for breast cancer.
    Fairney A; Morgan L; Barrett A; de Souza I; Barnes G
    Clin Oncol; 1976 Jun; 2(2):121-6. PubMed ID: 821686
    [No Abstract]   [Full Text] [Related]  

  • 6. Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients.
    Bhatavdekar JM; Patel DD; Shah NG; Giri DD; Vora HH; Karelia NH; Trivedi SN; Ghosh N; Suthar TP
    Neoplasma; 1992; 39(1):39-42. PubMed ID: 1388248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endocrine function tests in the evaluation of transsphenoidal hypophysectomy for advanced breast cancer.
    Lee DA; Davis RK; Komanicky P; Evjy JT; Strong MS; Mozden PJ
    Am J Surg; 1982 Apr; 143(4):481-5. PubMed ID: 6176133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer.
    Blackburn AM; Wang DY; Bulbrook RD; Thomas BS; Kwa HG; Hoare SA; Rubens RD
    Cancer Treat Rep; 1984 Dec; 68(12):1447-53. PubMed ID: 6239689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of chemotherapy on pituitary function in patients with advanced breast cancer.
    McFadyen IJ; Raab G; Cant E; Forrest AP; Groom GV; Griffiths K
    Clin Oncol; 1979 Jun; 5(2):153-7. PubMed ID: 466893
    [No Abstract]   [Full Text] [Related]  

  • 10. Pituitary function and clinical response in breast cancer patients after yttrium implantation.
    McFadyen IJ; Raab G; Buchan R; Forrest AP; Golder MP; Groom GV; Griffiths K
    Clin Oncol; 1979 Mar; 5(1):33-41. PubMed ID: 421386
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults.
    Kauppila M; Koskinen P; Irjala K; Remes K; Viikari J
    Bone Marrow Transplant; 1998 Aug; 22(4):331-7. PubMed ID: 9722067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation between prolactin and dehydroepiandrosterone sulfate in women with polycystic ovary disease].
    Bruno B; Poccia G; Masci A
    Minerva Endocrinol; 1985; 10(4):223-7. PubMed ID: 2939335
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pituitary hormone level in breast cancer patients].
    Agranat VZ; Valiura AV; Nikogosian GA
    Med Radiol (Mosk); 1981 Mar; 26(3):3-8. PubMed ID: 6783807
    [No Abstract]   [Full Text] [Related]  

  • 14. [Endocrinological aspects of puberal gynecomastia].
    Cicognani A; Villa MP; Cassio A; Ventura D; Becca A; Tassinari D; Cacciari E
    Minerva Pediatr; 1981 Jun; 33(11):507-14. PubMed ID: 6789052
    [No Abstract]   [Full Text] [Related]  

  • 15. Endocrine evaluation of patients with benign lumps of the breast.
    Mancini A; di Pietro C; de Marinis L; Rossi S; Lombardi CP; Iacona T; Bellantone R; Liberale I; Menini E; Crucitti F
    Cancer Detect Prev; 1992; 16(1):27-30. PubMed ID: 1532347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of drugs on the endocrine function tests (author's transl)].
    Suzuki H; Nakagawa K; Nakayama H; Kunita H; Hata S
    Rinsho Byori; 1974 Aug; 22(Suppl):326-51. PubMed ID: 4139294
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A
    J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen.
    Ravdin PM; Fritz NF; Tormey DC; Jordan VC
    Cancer Res; 1988 Feb; 48(4):1026-9. PubMed ID: 3123050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin F2alpha: effect on cortisol, growth hormone, luteinizing hormone, follicle-stimulating hormone, prolactin and thyroid-stimulating hormone.
    Vanderheyden K; Dhont M; Vandekerckhove D; Vermeulen A; Thiery M
    ICRS J Int Res Commun; 1974 Mar; 2(3):1164. PubMed ID: 4469240
    [No Abstract]   [Full Text] [Related]  

  • 20. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.